These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 449698)

  • 1. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians.
    Aronoff SL; Bennett PH; Unger RH
    J Clin Endocrinol Metab; 1977 May; 44(5):968-72. PubMed ID: 870519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA; Dupre J
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
    Raskin P; Pietri A; Unger R
    Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
    Werner PL; Palmer JP
    Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man.
    Benson JW; Johnson DG; Palmer JP; Werner PL; Ensinck JW
    J Clin Endocrinol Metab; 1977 Mar; 44(3):459-64. PubMed ID: 838846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
    Borghi VC; Wajchenberg BL; Cesar FP
    Metabolism; 1984 Dec; 33(12):1068-74. PubMed ID: 6390086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressibility of glucagon secretion by glucose in juvenile diabetes.
    Sperling MA; Aleck K; Voina S
    J Pediatr; 1977 Apr; 90(4):543-7. PubMed ID: 839365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon and diabetes. II. Complete suppression of glucagon by insulin in human diabetes.
    Warne GL; Alford FP; Chisholm DJ; Court J
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):277-84. PubMed ID: 862206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucoregulation in alloxan-diabetic dogs.
    Lussier B; Vranic M; Kovacevic N; Hetenyi G
    Metabolism; 1986 Jan; 35(1):18-24. PubMed ID: 3510360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute and chronic insulin administration on plasma IRG levels in human diabetes.
    Raskin P; Aydin I; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1531-3. PubMed ID: 979659
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.